Position Statements for Transcatheter Valve Therapies in Australia: Accreditation Standards and Heart Team Opportunities - 03/11/21
Doi : 10.1016/j.hlc.2021.09.011
Allan Davies, MBBS, MPH a, b, ⁎ 
, Ross Roberts-Thompson, MBBS, PhD c, Rishi Puri, MD, PhD d, Peter Psaltis, MBBS, PhD c, e, f
, Ross Roberts-Thompson, MBBS, PhD c, Rishi Puri, MD, PhD d, Peter Psaltis, MBBS, PhD c, e, f a Cardiovascular Department, John Hunter Hospital, Newcastle, NSW, Australia
b Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia
c Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia
d Cleveland Clinic, Cleveland, OH, USA
e Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
f Heart and Vascular Program, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
∗Corresponding author at: Cardiovascular Department, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, AustraliaCardiovascular DepartmentJohn Hunter HospitalLookout RoadNew Lambton HeightsNSWAustralia
Keywords : Transcatheter valve therapy, Transcatheter mitral valve therapy, Transcatheter aortic valve implantation, Position statements
Il testo completo di questo articolo è disponibile in PDF.
© 2021
Pubblicato da Elsevier Masson SAS.
Vol 30 - N° 12
P. 1787-1789 - dicembre 2021 Ritorno al numero
Articolo precedente
- Editorial Board
- Machine Learning in Risk Prediction for Cardiac Surgery – An Emerging Trend?
- Jaishankar Raman, Svetha Venkatesh, Rinaldo Bellomo
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?